Does molecular analysis increase the efficacy of bronchoalveolar lavage in the diagnosis and management of respiratory infections in hemato-oncological patients?

International Journal of Infectious Diseases

Volumn 50, Issue , 2016, Pages 48-53

  Oren, Ilana ^a,b   Hardak, Emilia ^b,c   Zuckerman, Tsila ^b,d   Geffen, Yuval ^e   Hoffman, Ron ^b,d   Yigla, Mordechai ^b,c   Avivi, Irit ^f,g  

^a Unit of Infectious Diseases   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Division of Pulmonary Medicine   (Israel)

^d Tel Aviv University ^*  (Israel)

^e Clinical Microbiology Laboratory   (Israel)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g TEL AVIV UNIVERSITY   (Israel)

Author keywords

Fiberoptic bronchoscopy with bronchoalveolar lavage; Hematological malignancies; Molecular analysis; Respiratory infections

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLUS; BACTERIAL PNEUMONIA; CANCER PATIENT; COUGHING; DYSPNEA; FEMALE; FIBEROPTIC BRONCHOSCOPY; HEMATOLOGIC MALIGNANCY; HEMOPTYSIS; HUMAN; LUNG INFILTRATE; LUNG LAVAGE; LUNG MYCOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PLEURISY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREDICTION; RESPIRATORY TRACT INFECTION; THORAX PAIN; ADOLESCENT; BACTERIUM; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CLASSIFICATION; CLINICAL TRIAL; COMPLICATION; FUNGUS; GENETICS; HEMATOLOGIC DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RESPIRATORY TRACT INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; FUNGI; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 84989886957     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.07.011     Document Type: Article

References (39)

1. 1 Sharma, S., Nadrous, H.F., Peters, S.G., Tefferi, A., Litzow, M.R., Aubry, M.C., et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest 128 (2005), 1385–1392.
2. 2 Shorr, A.F., Susla, G.M., O'Grady, N.P., Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest 125 (2004), 260–271.
3. 3 Camus, P., Costabel, U., Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med 26 (2005), 458–481.
4. 4 Von Eiff, M., Roos, N., Schulten, R., Hesse, M., Zuhlsdorf, M., van de Loo, J., Pulmonary aspergillosis: early diagnosis improves survival. Respiration 62 (1995), 341–347.
5. 5 Chamilos, G., Lewis, R.E., Kontoyiannis, D.P., Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47 (2008), 503–509.
6. 6 Verweij, P.E., van Die, L., Donnelly, J.P., Halo sign and improved outcome. Clin Infect Dis 44 (2007), 1666–1667 author reply 1667–8.
7. 7 Zihlif, M., Khanchandani, G., Ahmed, H.P., Soubani, A.O., Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 78 (2005), 94–99.
8. 8 Wang, J.Y., Chang, Y.L., Lee, L.N., Chen, J.H., Tang, J.L., Yang, P.C., et al. Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy. Ann Thorac Surg 78 (2004), 267–272.
9. 9 Lehto, J.T., Koskinen, P.K., Anttila, V.J., Lautenschlager, I., Lemstrom, K., Sipponen, J., et al. Bronchoscopy in the diagnosis and surveillance of respiratory infections in lung and heart–lung transplant recipients. Transpl Int 18 (2005), 562–571.
10. 10 Jain, P., Sandur, S., Meli, Y., Arroliga, A.C., Stoller, J.K., Mehta, A.C., Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 125 (2004), 712–722.
11. 11 Gruson, D., Hilbert, G., Valentino, R., Vargas, F., Chene, G., Bebear, C., et al. Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 28 (2000), 2224–2230.
12. 12 Boersma, W.G., Erjavec, Z., van der Werf, T.S., de Vries-Hosper, H.G., Gouw, A.S., Manson, W.L., Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL. Respir Med 101 (2007), 317–325.
13. 13 Peikert, T., Rana, S., Edell, E.S., Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates. Mayo Clin Proc 80 (2005), 1414–1420.
14. 14 Seneviratna, A., O'Carroll, M., Lewis, C.A., Milne, D., Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders. Intern Med J 42 (2012), 536–541.
15. 15 Hardak, E., Oren, I., Dann, E.J., Solomonov, A., Keren, R., Sprecher, H., et al. The yield of broncho-alveolar lavage in the diagnosis of pulmonary involvement among immune-suppressed patients with hematological disorders. J Bronchology Interv Pulmonol 13 (2006), 61–66.
16. 16 Hummel, M., Rudert, S., Hof, H., Hehlmann, R., Buchheidt, D., Diagnostic yield of bronchoscopy with bronchoalveolar lavage in febrile patients with hematologic malignancies and pulmonary infiltrates. Ann Hematol 87 (2008), 291–297.
17. 17 Shannon, V.R., Andersson, B.S., Lei, X., Champlin, R.E., Kontoyiannis, D.P., Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant 45 (2010), 647–655.
18. 18 Rabbat, A., Chaoui, D., Lefebvre, A., Roche, N., Legrand, O., Lorut, C., et al. Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?. Leukemia 22 (2008), 1361–1367.
19. 19 Durand-Joly, I., Chabe, M., Soula, F., Delhaes, L., Camus, D., Dei-Cas, E., Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol 45 (2005), 405–410.
20. 20 Tuon, F.F., A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 24 (2007), 89–94.
21. 21 Buchheidt, D., Baust, C., Skladny, H., Ritter, J., Suedhoff, T., Baldus, M., et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 33 (2001), 428–435.
22. 22 Raad, I., Hanna, H., Huaringa, A., Sumoza, D., Hachem, R., Albitar, M., Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 121 (2002), 1171–1176.
23. 23 Musher, B., Fredricks, D., Leisenring, W., Balajee, S.A., Smith, C., Marr, K.A., Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42 (2004), 5517–5522.
24. 24 De Pauw, B., Walsh, T.J., Donnelly, J.P., Stevens, D.A., Edwards, J.E., Calandra, T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008), 1813–1821.
25. 25 Hardak, E., Yigla, M., Avivi, I., Fruchter, O., Sprecher, H., Oren, I., Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome. Bone Marrow Transplant 44 (2009), 595–599.
26. 26 Avni, T., Levy, I., Sprecher, H., Yahav, D., Leibovici, L., Paul, M., Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol 50 (2012), 3652–3658.
27. 27 Ljungman, P., Griffiths, P., Paya, C., Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34 (2002), 1094–1097.
28. 28 Oren, I., Hardak, E., Finkelstein, R., Yigla, M., Sprecher, H., Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of Pneumocystis pneumonia. Am J Med Sci 342 (2011), 182–185.
29. 29 Skladny, H., Buchheidt, D., Baust, C., Krieg-Schneider, F., Seifarth, W., Leib-Mosch, C., et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 37 (1999), 3865–3871.
30. 30 Huang, S.N., Fischer, S.H., O'Shaughnessy, E., Gill, V.J., Masur, H., Kovacs, J.A., Development of a PCR assay for diagnosis of Pneumocystis carinii pneumonia based on amplification of the multicopy major surface glycoprotein gene family. Diagn Microbiol Infect Dis 35 (1999), 27–32.
31. 31 Chen, Y.C., Eisner, J.D., Kattar, M.M., Rassoulian-Barrett, S.L., Lafe, K., Bui, U., et al. Polymorphic internal transcribed spacer region 1 DNA sequences identify medically important yeasts. J Clin Microbiol 39 (2001), 4042–4051.
32. 32 Cloud, J.L., Carroll, K.C., Pixton, P., Erali, M., Hillyard, D.R., Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation. J Clin Microbiol 38 (2000), 1709–1712.
33. 33 Du Rand, I.A., Blaikley, J., Booton, R., Chaudhuri, N., Gupta, V., Khalid, S., et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax 68:Suppl 1 (2013), i1–i44.
34. 34 Campbell, S., Forbes, B.A., The clinical microbiology laboratory in the diagnosis of lower respiratory tract infections. J Clin Microbiol 49 (2011), S30–S33.
35. 35 Maschmeyer, G., Carratala, J., Buchheidt, D., Hamprecht, A., Heussel, C.P., Kahl, C., et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26 (2015), 21–33.
36. 36 Kuehnhardt, D., Hannemann, M., Schmidt, B., Heider, U., Possinger, K., Eucker, J., Therapeutic implication of BAL in patients with neutropenia. Ann Hematol 88 (2009), 1249–1256.
37. 37 Kottmann, R.M., Kelly, J., Lyda, E., Gurell, M., Stalica, J., Ormsby, W., et al. Bronchoscopy with bronchoalveolar lavage: determinants of yield and impact on management in immunosuppressed patients. Thorax, 66, 2011, 823.
38. 38 Brownback, K.R., Simpson, S.Q., Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients. Ann Thorac Med 8 (2013), 153–159.
39. 39 Hardak, E., Oren, I., Dann, E.J., Yigla, M., Faibish, T., Rowe, J.M., et al. The increased risk for Pneumocystis pneumonia in patients receiving rituximab-CHOP-14 can be prevented by the administration of trimethoprim/sulfamethoxazole: a single-center experience. Acta Haematol 127 (2012), 110–114.